Journey Medical Corporation

DERM

Offer Price Offer Size 3-Year Outlook Volatility 1st Day Turnover
$10.00 3,520,000 Positive High 109.92%

Offering Team

Deal Managers

  • B Riley

Lawyers

  • Alston & Bird LLP

Auditors

  • KPMG LLP

Pre-IPO Investors

Investors

  • Google Ventures
  • Intel Ventures
  • Patricoff Ventures
  • Kleiner Perkins

Pre-IPO Holdings(%)

  • 30
  • 20
  • 05
  • 18

Deal Highlights

Journey Medical Corporation is a commercial-stage pharmaceutical company founded in October 2014 that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. Our current portfolio includes five branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the U.S. We are managed by experienced life science executives with a track record of creating value for th More

Deal Tracker

Investors

Filing

10 Nov, 2021

Offer

12 Nov, 2021

Look Ahead

Lock Up Expiry

12 May, 2022

Earning

Nov 1, 2018

IPO Terms

Offer Price $10.00
Offer Size 3M

Market Sentiments

Stock Price